Glac Biotech Co., Ltd.

Yi-Chun Tsai

Pei-Shan Hsieh

Hsieh-Hsun Ho

Chung-Wei Kuo

Yi-Wei Kuo

Jiu-Yao Wang

Hung-Chih Lin

Yi Wei Kuo

Albert Kuo

Yi-Chun Chen

A method of inhibiting oral pathogens comprising administering to a subject in need thereof an effective amount ofstrain-containing food composite, medical composite and oral cleaning composite. The food composite, medical composite and oral cleaning composite comprises at least onestrain, which is at least one isolatedstrain selected from a group includingF-1 strain, CCTCC NO: M2011124;subsp.AP-32 strain, CCTCC NO: M2011127;GL-104 strain, CCTCC NO: M209138;GL-156 strain, CCTCC NO: M2014590;RE-78 strain, CGMCC No. 13513;CT-53 strain, CCTCC NO: M2011129; andET-66 strain, CGMCC No. 13514, which are respectively preserved in China Center for Type Culture Collection (CCTCC) and China General Microbiological Culture Collection Center (CGMCC).

Method of inhibiting oral pathogens

A food composition and pharmaceutical composition with strains of lactic acid bacteria for reducing blood uric acid concentration are provided, comprising at least one or two isolated lactic acid bacteria strains selected from the following two: TSF331 () and TSR332 ().

Method for reducing blood uric acid concentration and for degrading purine

A food composition and pharmaceutical composition with strains of lactic acid bacteria for modulating blood glucose are provided, comprising an isolated lactic acid bacteria strain. The isolated lactic acid bacteria strain is at least one selected from a group including a GL-104 strain of(CCTCC NO: M209138), an AP-32 strain ofsubsp.(CCTCC NO: M2011127), a TYCA06 strain of(CGMCC No: 15210), and an MH-68 strain of(CCTCC NO: M2011128), or a combination thereof.

Food composition and pharmaceutical composition with strains of lactic acid bacteria and method for modulating blood glucose

The present invention provides astrain-containing pharmaceutical composition and food composition for improving of kidney disease and inhibiting inflammation, which comprises an isolated lactic acid bacteria strain. The isolated lactic acid bacteria strain is at least one selected from a group including BLI-02 strain, CGMCC No. 15212,subsp., TYCA06 strain, CGMCC No. 15210,, VDD088 strain, CGMCC No. 15211,, and combinations thereof.

Pharmaceutical composition and food composition with strains of lactic acid bacteria for improving of kidney disease and inhibiting inflammation

An anti-inflammatory and anti-vaginitis food composition and/or pharmaceutical composition includessubsp.AP-32 (CCTCC stock No. M2011127),TE-33 (CCTCC stock No. M2011126),F-1 (CCTCC stock No. M2011124),CT-53 (CCTCC stock No. M2011129) or combinations thereof. The present invention may inhibit TNF-&#x3b1; secretion and promote IL-10 secretion of dendritic cells and therefore inhibit inflammation, particularly inflammation of vagina mucosa cells. The present invention may be presented as oral probiotics and direct-use vagina probiotics.

Growing community of inventors

Tainan, Taiwan

Yi-Chun Tsai